The U.S. Food and Drug Administration is working with Deerfield, Ill.-based Baxter Healthcare, Evanston, Ill.-based B. Braun Medical and Lake Forest, Ill.-based Hospira to address the issue, according to the news release.
More Articles on the FDA:
FDA Bans Ranbaxy Laboratories From Manufacturing, Importing Drugs
FDA Drug Approval Processes Not Consistent
FDA Appoints Dr. Rafael Miguel to Anesthetic and Analgesic Drug Products Advisory Committee
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
